Seaport Therapeutics Publishes Research on Glyph™ Platform’s 55% Lymphatic Drug Absorption
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company specializing in novel neuropsychiatric medicines, has announced the publication of groundbreaking research on its Glyph™ platform. The study, published in…
Taiho Oncology Europe Announces Availability of Futibatinib in Italy for the Treatment of Cholangiocarcinoma
Taiho Oncology Europe Announces Availability of Futibatinib in Italy for the Treatment of Cholangiocarcinoma Taiho Oncology Europe, a subsidiary of Taiho Pharmaceutical Co., Ltd., has officially announced the availability of…
GenSight Biologics Reports Five-Year Efficacy and Safety Results of LUMEVOQ® Gene Therapy from the REFLECT Study
GenSight Biologics Reports Five-Year Efficacy and Safety Results of LUMEVOQ® Gene Therapy from the REFLECT Study GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company dedicated to developing…
Arrowhead Pharmaceuticals Completes Global License and Collaboration Deal with Sarepta Therapeutics
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has successfully closed its global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT), which was initially announced on November 26, 2024. The closing of…
Incyte Announces Q4 and Full-Year 2024 Financial Results, Shares 2025 Guidance and R&D Milestones
Incyte Announces Q4 and Full-Year 2024 Financial Results, Shares 2025 Guidance and R&D Milestones Incyte reported its financial results for the fourth quarter and full year ended December 31, 2024.…
Aurion Biotech Names Donald Munoz as Chief Financial Officer
Aurion Biotech, Inc. (Aurion), a company dedicated to restoring vision for millions through transformative regenerative therapies, has announced the appointment of Donald Munoz as Chief Financial Officer (CFO). Munoz will…
KalVista Presents New Sebetralstat Data at WSAAI 2025
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced the presentation of novel data on long-term prophylaxis (LTP) and sebetralstat at the Western Society of Allergy, Asthma & Immunology (WSAAI) 2025 Annual…
Bristol Myers Squibb Reports Positive Breyanzi® Results in Relapsed Marginal Zone Lymphoma
Bristol Myers Squibb (NYSE: BMY) has announced positive topline results from the Phase 2 TRANSCEND FL trial, evaluating Breyanzi® (lisocabtagene maraleucel) in adult patients with relapsed or refractory indolent B-cell…
Nutriband Secures U.S. Patent Approval for Aversa™ Transdermal Abuse Deterrent Technology
Nutriband Secures U.S. Patent Approval for Aversa™ Transdermal Abuse Deterrent Technology Nutriband a pharmaceutical company specializing in the development of prescription transdermal products, recently announced that it has received a…
Kidney Transplant Eledon Pharma Highlights Tegoprubart in Second Pig Kidney Transplant to Human
Kidney Transplant Eledon Pharmaceuticals Advances Xenotransplantation with Tegoprubart Kidney Transplant Eledon Pharmaceuticals has announced that its investigational anti-CD40L antibody, tegoprubart, was a crucial component of the immunosuppression regimen used in…
Regeneron (REGN) Shareholders Urged to Join Class Action – Contact Levi & Korsinsky for Details
Levi & Korsinsky, LLP Announces Securities Fraud Lawsuit Against Regeneron Pharmaceuticals, Inc. Levi & Korsinsky, LLP has issued a notice to investors in Regeneron Pharmaceuticals the regarding a class action…
Protein Prediction LG Develops AI-Powered Protein Prediction for Drug Discovery
Protein Prediction LG Develops Next-Generation AI for Protein Structure Prediction to Revolutionize Drug Discovery On February 5th, LG AI Research took a significant step in advancing the field of artificial…